These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 18560537)
21. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP. Giannini D; Di Franco A; Tonelli M; Bartoli ML; Carnevali S; Cianchetti S; Bacci E; Dente FL; Vagaggini B; Paggiaro PL Respir Med; 2003 May; 97(5):463-7. PubMed ID: 12735661 [TBL] [Abstract][Full Text] [Related]
22. Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects. Singh D; Siew L; Christensen J; Plumb J; Clarke GW; Greenaway S; Perros-Huguet C; Clarke N; Kilty I; Tan L Eur J Clin Pharmacol; 2015 Oct; 71(10):1175-84. PubMed ID: 26265232 [TBL] [Abstract][Full Text] [Related]
23. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996 [TBL] [Abstract][Full Text] [Related]
24. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907 [TBL] [Abstract][Full Text] [Related]
25. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK; Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444 [TBL] [Abstract][Full Text] [Related]
26. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Godon P; Boulet LP; Malo JL; Cartier A; Lemière C Eur Respir J; 2002 Dec; 20(6):1364-9. PubMed ID: 12503690 [TBL] [Abstract][Full Text] [Related]
28. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. Di Franco A; Bacci E; Bartoli ML; Cianchetti S; Dente FL; Taccola M; Vagaggini B; Zingoni M; Paggiaro PL Pulm Pharmacol Ther; 2006; 19(5):353-60. PubMed ID: 16289980 [TBL] [Abstract][Full Text] [Related]
29. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast. Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419 [TBL] [Abstract][Full Text] [Related]
30. Sputum induction and bronchoscopy for assessment of ozone-induced airway inflammation in asthma. Arjomandi M; Schmidlin I; Girling P; Boylen K; Ferrando R; Balmes J Chest; 2005 Jul; 128(1):416-23. PubMed ID: 16002965 [TBL] [Abstract][Full Text] [Related]
31. Effects of short-term exposure to 0.2 ppm ozone on biomarkers of inflammation in sputum, exhaled nitric oxide, and lung function in subjects with mild atopic asthma. Newson EJ; Krishna MT; Lau LC; Howarth PH; Holgate ST; Frew AJ J Occup Environ Med; 2000 Mar; 42(3):270-7. PubMed ID: 10738706 [TBL] [Abstract][Full Text] [Related]
32. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways. Lay JC; Peden DB; Alexis NE Inhal Toxicol; 2011 Jun; 23(7):392-406. PubMed ID: 21639708 [TBL] [Abstract][Full Text] [Related]
34. Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. Wallin A; Sue-Chu M; Bjermer L; Ward J; Sandström T; Lindberg A; Lundbäck B; Djukanović R; Holgate S; Wilson S J Allergy Clin Immunol; 2003 Jul; 112(1):72-8. PubMed ID: 12847482 [TBL] [Abstract][Full Text] [Related]
35. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Booth H; Richmond I; Ward C; Gardiner PV; Harkawat R; Walters EH Am J Respir Crit Care Med; 1995 Jul; 152(1):45-52. PubMed ID: 7599861 [TBL] [Abstract][Full Text] [Related]
36. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. Alexis NE; Zhou H; Lay JC; Harris B; Hernandez ML; Lu TS; Bromberg PA; Diaz-Sanchez D; Devlin RB; Kleeberger SR; Peden DB J Allergy Clin Immunol; 2009 Dec; 124(6):1222-1228.e5. PubMed ID: 19796798 [TBL] [Abstract][Full Text] [Related]
37. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma. Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383 [TBL] [Abstract][Full Text] [Related]
38. Fluticasone propionate attenuates ozone-induced rhinitis and mucous cell metaplasia in rat nasal airway epithelium. Hotchkiss JA; Hilaski R; Cho H; Regan K; Spencer P; Slack K; Harkema JR Am J Respir Cell Mol Biol; 1998 Jan; 18(1):91-9. PubMed ID: 9448050 [TBL] [Abstract][Full Text] [Related]
39. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Gershman NH; Wong HH; Liu JT; Fahy JV Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614 [TBL] [Abstract][Full Text] [Related]
40. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients. Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]